Randomized within‐subject trial to evaluate smokers’ initial perceptions, subjective effects and nicotine delivery across six vaporized nicotine products.
Population Clinical
Cessation
Tobacco
Voos (2019)
age differences in electronic nicotine delivery systems (ENDS) usage motivations and behaviors, perceived health benefit, and intention to quit.
Population Clinical
Consumer Use
Reasons For Use
Vu (2019)
Predicting the long-term effects of electronic cigarette use on population health: a systematic review of modelling studies.
Population Clinical
Population Health Impact
Vu (2023)
Perceptions about levels of harmful chemicals in e-cigarettes relative to cigarettes, and associations with relative e-cigarette harm perceptions, e-cigarette use and interest.
Population Clinical
Perceptions Of Risk
Comparison With Tobacco Or Other Nicotine Products
Wackowski (2023)
Young adult E-Cigarette and Combustible Tobacco Users attitudes, Substance Use Behaviors, Mental health, and Neurocognitive Performance.
Population Clinical
Population Health Impact
Wade (2022)
Modeling the public health impact of e-cigarettes on adolescents and adults.
Population Clinical
Population Health Impact
Wagner (2021)
Changes in knowledge, perceptions and use of JUUL among a cohort of young adults.
Population Clinical
Consumer Use
Youth Use & Appeal
Wagoner (2021)
Nicotine patches used in combination with e-cigarettes (with and without nicotine) for smoking cessation: a pragmatic, randomised trial.
Population Clinical
Cessation
Tobacco
Walker (2020)
Use of e-cigarettes and smoked tobacco in youth aged 14-15 years in New Zealand: findings from repeated cross-sectional studies (2014-19).
Population Clinical
Consumer Use
Youth Use & Appeal
Walker (2020)
associations of history of mental illness with smoking and vaping among university students aged 18-24 years in New Zealand: Results of a 2018 national cross-sectional survey.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Wamamili (2021)